Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Oct 13, 2026

UNCY — Unicycive Therapeutics, Inc. Dilution Risk Tracker

Track UNCY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UNCY — Get alerts when the score changes →

As of October 13, 2026, Unicycive Therapeutics, Inc. (UNCY) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. Unicycive Therapeutics, Inc. has a market capitalization of $112.81M, 27.86M shares outstanding, 51 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for UNCY.
🔔 Track UNCY — Get forecast alerts →

Market Data

Market Cap$112.81M
Shares Outstanding27.86M
Float24.28M
Cash$61.42M
Debt$815.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore40/100DilutionWatch score record
Shares Outstanding27.86MVerified float table or market cache
Public Float24.28MVerified float table or market cache
Market Cap$112.81MMarket data cache
Cash Runway28.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 60.4% shares (2026Q1 vs prior)
51 institutional holders · 13.16M shares
#1 Vivo Capital, LLC 3.58M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 1.62M shares
#3 MILLENNIUM MANAGEMENT LLC 1.40M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.85M
Days to Cover5.7
% of Float20.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-30
xbrl XBRL CONVERTIBLE 2023-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual UNCY Dilution Snapshot

Unicycive Therapeutics, Inc. (UNCY) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

UNCY's DilutionScore is currently 40/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 41/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202640/100MEDIUM53 days
Aug 14 – Aug 21, 202641/100MEDIUM7 days
Jul 16 – Aug 13, 202640/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

UNCY shares outstanding have increased 20.7% from 22.11M (Mar 2026) to 26.70M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202626.70M24.28M▲ 6.41%
Apr 07, 202625.24M22.82M▲ 8.56%
Mar 31, 202622.11M21.02M▲ 17.43%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track UNCY Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment UNCY files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking UNCY — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for UNCY
UNCY FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.